--- title: 'Regional Marketing Director at Summit Therapeutics' canonical: 'https://feeny.ai/job/regional-marketing-director-summit-therapeutics-princeton-p443zfx10fsb' type: 'job' last_seen: '2026-10-16' --- # Regional Marketing Director at Summit Therapeutics - **Company:** Summit Therapeutics - **Location:** Princeton, NJ - **Compensation:** $190k–$228k - **Work type:** remote - **Posted:** 2026-10-14 - **Last confirmed live:** 2026-10-16 - **Apply:** https://job-boards.greenhouse.io/summittherapeutics/jobs/4450641009 ## Job description About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Job Title: Regional Marketing Director Department: US Marketing Location: Remote-Field ## REGIONAL MARKETING DIRECTOR Overview of Role: The Regional Marketing Director will play a critical role in supporting the successful commercialization of Summit Therapeutics' oncology portfolio by developing and executing regional marketing strategies and customer engagement initiatives that align with the Company's overall brand and commercial strategy. The Regional Marketing Director will serve as a key partner to the field organization, Marketing, Sales, Medical Affairs, Market Access, and other cross-functional stakeholders to translate national brand strategies into impactful regional execution. This role will develop differentiated engagement strategies for key customers and thought leaders, leverage customer insights to enable highly personalized interactions, and support congress, advisory board, and promotional speaker initiatives. Role and Responsibilities: - Develop and execute regional marketing strategies and educational initiatives that align with national brand strategy, commercial objectives, and the evolving needs of the oncology marketplace. - Develop and execute robust customer engagement plans for National and Regional Thought Leaders, including identification, segmentation, engagement planning, and coordination of appropriate cross-functional interactions. - Partner closely with Sales and other customer-facing teams to translate national marketing strategies into effective regional execution plans and identify opportunities to enhance customer engagement. - Develop and enable a 360-degree view of regional and national thought leaders, integrating available customer insights, engagement history, affinity data, affiliations, and other relevant information to help field teams appropriately personalize customer interactions. - Partner cross-functionally to identify customer insights and regional market dynamics and translate those insights into actionable recommendations for the broader commercial organization. - Support the identification, recruitment, contracting, and execution of regional and national commercial advisory boards, ensuring appropriate planning, coordination, and execution in partnership with relevant stakeholders. - Develop and execute national and regional congress strategies and plans, with a particular focus on Tier 1 and Tier 2 congresses, to maximize customer engagement, educational opportunities, and commercial impact. - Partner with Sales and cross-functional stakeholders to develop pre-, during-, and post-congress engagement strategies and ensure effective follow-up with priority customers and thought leaders. - Support the recruitment, education, contracting, and execution of the Promotional Speakers Program, working closely with internal stakeholders to ensure effective and compliant program execution. - Develop and maintain strong relationships with internal stakeholders across Marketing, Sales, Medical Affairs, Market Access, Commercial Operations, Legal, Compliance, and other functions to ensure coordinated regional execution. - Create and participate in regular regional insight-sharing forums with the field organization to capture customer feedback, competitive intelligence, market dynamics, and emerging opportunities and translate insights into actionable recommendations. - Serve as a key conduit between the field organization and the broader Commercial organization, ensuring regional customer insights inform national marketing strategy and execution. - Ensure all regional marketing activities and customer engagements are executed in accordance with Company policies, applicable laws and regulations, and established compliance requirements. - All other duties as assigned Experience, Education and Specialized Knowledge and Skills: - Bachelor's degree in Marketing, Business, or a related field, or an equivalent combination of education and experience; advanced degree preferred. - Minimum of 10+ years of progressive experience in pharmaceutical, biotechnology, or healthcare marketing, with demonstrated experience supporting commercial products and/or launches. - Demonstrated experience developing and executing regional marketing strategies and customer engagement plans within the U.S. pharmaceutical or biopharmaceutical industry. - Experience working within oncology is required with lung cancer experience preferred - Demonstrated understanding of the U.S. healthcare environment and experience engaging with National and Regional Thought Leaders and other key healthcare stakeholders. - Experience supporting commercial advisory boards, speaker programs, congress strategy/execution, and other customer engagement initiatives. This is the pay for this position Pay Transparency $190,000—$228,000 USD Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation. Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit. Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. ## About Summit Therapeutics ## Company Overview - **One-liner**: Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on discovering, developing, and commercializing novel bispecific antibody therapies, with its lead candidate ivonescimab targeting PD-1 and VEGF for multiple solid tumors. - **Entity Type**: Public (NASDAQ: SMMT) - **Headquarters**: Miami, Florida, USA (with additional offices in Palo Alto, CA; Princeton, NJ; Oxford, UK; and Dublin, Ireland) - **Founded**: 2003 - **Founders**: Not publicly disclosed on the company website; the company was founded in 2003. ## Core Business - **Primary industry**: Biopharmaceuticals / Oncology - **Target customers**: B2B (healthcare providers, patients, and caregivers) with a focus on resolving serious unmet medical needs in oncology - **Mission statement**: "To resolve serious, unmet medical needs for the betterment of overall human health." [smmttx.com](https://smmttx.com/company/about-us/default.aspx) ## Products & Services - **Ivonescimab (SMT112)**: A novel, potential first-in-class investigational bispecific antibody targeting both PD-1 and VEGF. It is designed to combine immunotherapy (PD-1 blockade) with anti-angiogenesis (VEGF blockade) into a single molecule. Currently being studied in several global Phase 3 clinical trials for non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and head and neck squamous cell carcinoma (HNSCC). Licensed from Akeso, Inc. (HKEX: 9926.HK) for territories including the U.S., Canada, Europe, Japan, Latin America, the Middle East, and Africa. [smmttx.com](https://smmttx.com/pipeline/default.aspx) ## Market Standing - **Valuation/Market Cap**: Approximately $2.7 billion (as of recent data) [linkedin.com](https://www.linkedin.com/company/summit-therapeutics) - **Key Metric**: Annual revenue of approximately $705,000 (reported). The company is pre-commercialization and heavily investing in R&D. Total funding raised since IPO (2015) is not disclosed, but the company has a strong cash position from equity offerings. - **Notable Investors/Partners**: Akeso, Inc. (key licensing partner for ivonescimab). The company is publicly traded with institutional and retail investors. - **Growth Signals**: - Headcount grew 72.5% year-over-year to 244 employees. [linkedin.com](https://www.linkedin.com/company/summit-therapeutics) - Multiple global Phase 3 trials actively recruiting (HARMONi, HARMONi-3, HARMONi-7, HARMONi-GI3, ILLUMINE). - Over 4,000 patients have been treated with ivonescimab across all clinical trials globally. [smmttx.com](https://smmttx.com/pipeline/default.aspx) - Achieved Great Place to Work® Certification. [smmttx.com](https://smmttx.com/careers/careers-overview/default.aspx) ## Competitive Advantages - **Novel Mechanism**: Ivonescimab is a first-in-class bispecific antibody targeting both PD-1 and VEGF simultaneously, potentially offering superior efficacy and fewer side effects compared to combination therapies. - **Speed and Execution**: The company emphasizes "high-speed execution in commercialization" and has rapidly initiated multiple Phase 3 trials. - **Global Reach**: Licensed territories cover major markets (U.S., Canada, Europe, Japan, Latin America, Middle East, Africa) with a strong partner (Akeso) in the rest of the world. - **Strong Balance Sheet**: With a $2.7B market cap and public listing, the company has access to capital markets to fund its pipeline. ## Strategic Focus - **Current priorities**: Advancing ivonescimab through Phase 3 clinical trials across multiple solid tumor indications (NSCLC, CRC, HNSCC), with the goal of regulatory approval and commercialization. - **Future direction**: Expanding the pipeline into additional solid tumors and leveraging the bispecific platform for future therapies. The company is focused on becoming a leading oncology player. - **Near-term milestones**: Data readouts from ongoing Phase 3 trials, potential regulatory submissions, and building commercial infrastructure. ## Why Work Here - **Culture**: The company has achieved Great Place to Work® Certification, indicating a positive, supportive, and fulfilling work environment. Core values include Commitment to People, Integrity, Passion for Excellence, Purposeful Urgency, Accountability, and Collaboration. [smmttx.com](https://smmttx.com/careers/careers-overview/default.aspx) - **Work Environment**: Fast-paced, high-energy atmosphere focused on innovation and collaboration. The company emphasizes "making a significant difference in patients’ lives." - **Benefits (U.S.)**: - 401(k) with 6% employer match - Employee Stock Purchase Plan (ESPP) with 15% discount up to the annual federal limit - Flexible Spending Account - Commuter Benefit - Onsite lunch provided - **Benefits (U.K.)**: - Private Medical Insurance - Employee Assistance Program - Life Assurance Policy - Company Pension Contributions - ESPP - **Remote/Hybrid Policy**: Not explicitly stated, but multiple office locations suggest a hybrid or on-site presence is expected for many roles. - **Open Roles**: 25 active job postings (as of recent data) including Senior Director of Sales Operations, Clinical Scientists, Medical Science Liaisons, and Drug Product MSAT roles. [greenhouse.io](https://job-boards.greenhouse.io/summitherrapeutics) - **Headcount Growth**: 72.5% year-over-year growth signals a scaling organization with opportunities for career advancement. ## Sources 1. [smmttx.com - About Us](https://smmttx.com/company/about-us/default.aspx) 2. [smmttx.com - Investor Relations Overview](https://www.smmttx.com/overview/default.aspx) 3. [smmttx.com - Pipeline](https://smmttx.com/pipeline/default.aspx) 4. [smmttx.com - Careers Overview](https://smmttx.com/careers/careers-overview/default.aspx) 5. [linkedin.com - Summit Therapeutics Company Page](https://www.linkedin.com/company/summit-therapeutics) 6. [greenhouse.io - Summit Therapeutics Careers](https://job-boards.greenhouse.io/summitherrapeutics) ## Other roles at Summit Therapeutics - [Senior Principal Scientist](https://feeny.ai/job/senior-principal-scientist-summit-therapeutics-palo-alto-n0strqh510r6) — Palo Alto, CA - [Associate Director, Clinical Supply Management (UK/EU)](https://feeny.ai/job/associate-director-clinical-supply-management-uk-eu-summit-therapeutics-oxford-4hve8zj7pay9) — Oxford UK Zug Switzerland Dublin, Ireland - [Director, Sourcing & Procurement - R&D Clinical Operations and Supplies](https://feeny.ai/job/director-sourcing-procurement-r-d-clinical-operations-and-supplies-summit-1ctpcgpnyv4w) — United States - [Associate Director, Clinical Supply Management](https://feeny.ai/job/associate-director-clinical-supply-management-summit-therapeutics-princeton-nj-mvc6azpxcvpd) — Princeton NJ US and Palo Alto CA, United States - [Director, Clinical Scientist](https://feeny.ai/job/director-clinical-scientist-summit-therapeutics-united-states-4b7fcrb9mkfb) — United States - [Senior Medical Director](https://feeny.ai/job/senior-medical-director-summit-therapeutics-united-states-6d943xf75bpx) — United States - [Senior Director, Oncology Clinical Educators](https://feeny.ai/job/senior-director-oncology-clinical-educators-summit-therapeutics-field-8pyx53adkr7g) — Field, United States - [Director, Clinical Operations Analytics & Performance Excellence](https://feeny.ai/job/director-clinical-operations-analytics-performance-excellence-summit-wqz1bgajvnrd) - [Corporate Counsel, Clinical Contracts](https://feeny.ai/job/corporate-counsel-clinical-contracts-summit-therapeutics-united-states-kr3cyb13nj9c) — United States - [Associate Director, Medical Writing](https://feeny.ai/job/associate-director-medical-writing-summit-therapeutics-remote-gq102xpjcf7z)